TOP STORIES

• BUSINESS Takeda Looks to House 3,000 Researchers at Shonan Innovation Park, Create Fund by March
  October 16, 2017

• ACADEMIA Nephrology Society to Build Database, Biobank to Support Drug Discovery; Some 20 Companies Interested in Collaboration
  October 13, 2017

• REGULATORY FPMAJ Chief Trades Barbs with Chuikyo Payer Rep, Says Western-Style HTA Doesn’t Fit Japan’s Unique Market Mechanism
  October 12, 2017

• REGULATORY Any CEA-Based Price Adjustment Must Be Limited to Premium Rates: 3 Pharma Groups
  October 11, 2017

• REGULATORY MHLW to Issue Basic Guide to PMS for Conditional Early Approval: Drug Review Chief
  October 11, 2017

• REGULATORY Japan Needs “Quick and Low-Cost” R&D Setup: Top MD Bureaucrat
  October 10, 2017

• REGULATORY MHLW to Place Priority on “Mutual Understanding” with Industry: Economic Affairs Chief
  October 6, 2017

• REGULATORY Payers Oppose Price Hikes based on CEA at 1st Joint Meeting: Chuikyo
  October 5, 2017

• BUSINESS Japan Debut of MSD’s Zetia/Lipitor Combo Delayed as Cyberattack Woes Continue
  October 4, 2017

• REGULATORY MHLW Wants to Introduce Conditional Early Approval System This Month: Minister
  October 3, 2017

• REGULATORY (Update) Bayer Told to Improve Practice over ADR Reporting Delays, Gets “Verbal Guidance” for Xarelto Survey Fuss
  October 2, 2017

• REGULATORY MHLW Unveils Planned Framework for Conditional Early Approval Scheme
  September 29, 2017

• REGULATORY MHLW OKs Japan’s 1st PD-L1 Inhibitor, 8-Week Hep C Med, Ibrance and More
  September 28, 2017

• REGULATORY As Complaints of Shortages Grow for Japanese Encephalitis Vaccine, MHLW Plans Centralized Collection/Feedback of Supply-Demand Data for Distributers
  September 27, 2017

• TRENDS Japan’s “NDB” Insurance Claim Database Corroborates Slack SGLT-2 Prescriptions for Older People in FY2015
  September 26, 2017

• BUSINESS Opdivo Gains Nod for Gastric Cancer; Spinraza Now Available for All SMA Patients
  September 25, 2017

• BUSINESS Medipal to Become JCR’s Top Shareholder, Poised to Form JV in US
  September 22, 2017

• BUSINESS CSL Ramping Up Investment for New Product Development, 11% R&D-to-Sales Ratio “Appropriate”: CEO
  September 22, 2017

• REGULATORY Kaketsuken in Talks with “Several Entities” over Possible Biz Transfer: New Chief
  September 21, 2017

• BUSINESS NCC, Top 3 Japan Makers Form Immunotherapy Consortium with Eye on Alternative to PD-1 Inhibitors
  September 20, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 151
• 152
• 153
• 154
• 155
• 156
• 157
• 158
• 159
• …
• Next ›
• 最終 »